{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:34:26Z","timestamp":1768343666808,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870651"],"award-info":[{"award-number":["81870651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870675"],"award-info":[{"award-number":["81870675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171042"],"award-info":[{"award-number":["82171042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["20JCZDJC00100"],"award-info":[{"award-number":["20JCZDJC00100"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.exer.2023.109572","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T21:33:59Z","timestamp":1689197639000},"page":"109572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["TNFAIP8 overexpression aggravates retinal pathophysiological features of diabetic retinopathy"],"prefix":"10.1016","volume":"234","author":[{"given":"Fuhua","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-2797","authenticated-orcid":false,"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.exer.2023.109572_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","article-title":"Current understanding of the molecular and cellular pathology of diabetic retinopathy","volume":"17","author":"Antonetti","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","article-title":"VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy","volume":"54","author":"Arrigo","year":"2022","journal-title":"Ann. Med."},{"issue":"10","key":"10.1016\/j.exer.2023.109572_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102974","article-title":"TIPE family of proteins and its implications in different chronic diseases","volume":"19","author":"Bordoloi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.exer.2023.109572_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2023.109572_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.exer.2023.109572_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040617","article-title":"Contribution of muller cells in the diabetic retinopathy development: focus on oxidative stress and inflammation","volume":"11","author":"Carpi-Santos","year":"2022","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.exer.2023.109572_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2337\/db16-1246","article-title":"Pathogenic role of microRNA-21 in diabetic retinopathy through downregulation of PPARalpha","volume":"66","author":"Chen","year":"2017","journal-title":"Diabetes"},{"issue":"9735","key":"10.1016\/j.exer.2023.109572_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157339907779802139","article-title":"Leukocytes in diabetic retinopathy","volume":"3","author":"Chibber","year":"2007","journal-title":"Curr. Diabetes Rev."},{"issue":"2","key":"10.1016\/j.exer.2023.109572_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4239\/wjd.v6.i2.312","article-title":"Current knowledge on diabetic retinopathy from human donor tissues","volume":"6","author":"Eisma","year":"2015","journal-title":"World J. Diabetes"},{"issue":"11","key":"10.1016\/j.exer.2023.109572_bib11","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ophtha.2012.08.022","article-title":"Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results","volume":"119","author":"Elman","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.exer.2023.109572_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrn3783","article-title":"Retinal bipolar cells: elementary building blocks of vision","volume":"15","author":"Euler","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","article-title":"Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond","volume":"61","author":"Hammes","year":"2018","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.exer.2023.109572_bib14","first-page":"451","article-title":"Diabetic retinopathy","volume":"42","author":"Hendrick","year":"2015","journal-title":"PrimaryCare"},{"issue":"10","key":"10.1016\/j.exer.2023.109572_bib15","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood.V93.10.3418.410k23_3418_3431","article-title":"Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes","volume":"93","author":"Horrevoets","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib16","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5226","article-title":"Current research status of TNFAIP8 in tumours and other inflammatory conditions","volume":"59","author":"Hua","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.exer.2023.109572_bib17","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1167\/iovs.10-5768","article-title":"TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis","volume":"52","author":"Huang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.exer.2023.109572_bib18","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1167\/iovs.09-3724","article-title":"Spectral domain optical coherence tomography in mouse models of retinal degeneration","volume":"50","author":"Huber","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109572_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41433-021-01722-8","article-title":"Next-generation anti-VEGF agents for diabetic macular oedema","volume":"36","author":"Iglicki","year":"2022","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.exer.2023.109572_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9090891","article-title":"Importance of the use of oxidative stress biomarkers and inflammatory profile in aqueous and vitreous humor in diabetic retinopathy","volume":"9","author":"Lopez-Contreras","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2023.109572_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-022-02127-x","article-title":"Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis","author":"Mason","year":"2022","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.exer.2023.109572_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/08820539909069542","article-title":"Pathogenetic potential of leukocytes in diabetic retinopathy","volume":"14","author":"Miyamoto","year":"1999","journal-title":"Semin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2023.109572_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/diabetes.47.3.445","article-title":"Muller cell changes in human diabetic retinopathy","volume":"47","author":"Mizutani","year":"1998","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010009","article-title":"Oncogenic role of tumor necrosis factor alpha-induced protein 8 (TNFAIP8)","volume":"8","author":"Niture","year":"2018","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.exer.2023.109572_bib26","first-page":"29","article-title":"TNFAIP8: inflammation, immunity and human diseases","volume":"1","author":"Niture","year":"2019","journal-title":"J Cell Immunol"},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010009","article-title":"Oncogenic role of tumor necrosis factor alpha-induced protein 8 (TNFAIP8)","volume":"8","author":"Niture","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.exer.2023.109572_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2018.06.017","article-title":"Novel tumor necrosis factor-alpha induced protein eight (TNFAIP8\/TIPE) family: functions and downstream targets involved in cancer progression","volume":"432","author":"Padmavathi","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.exer.2023.109572_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2018.06.017","article-title":"Novel tumor necrosis factor-alpha induced protein eight (TNFAIP8\/TIPE) family: functions and downstream targets involved in cancer progression","volume":"432","author":"Padmavathi","year":"2018","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.exer.2023.109572_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tem.2020.01.005","article-title":"Muller cell metabolic signatures: evolutionary conservation and disruption in disease","volume":"31","author":"Pfeiffer","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","article-title":"Role of interleukin-1beta during pain and inflammation","volume":"60","author":"Ren","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"6","key":"10.1016\/j.exer.2023.109572_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2023.109572_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.exer.2023.109572_bib35","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00125-017-4381-5","article-title":"Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes","volume":"60","author":"Tonade","year":"2017","journal-title":"Diabetologia"},{"issue":"1\u20132","key":"10.1016\/j.exer.2023.109572_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2006.09.015","article-title":"TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage","volume":"182","author":"Vinores","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.exer.2023.109572_bib37","doi-asserted-by":"crossref","first-page":"O68","DOI":"10.1167\/iovs.17-21769","article-title":"Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach","volume":"58","author":"Vujosevic","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2023.109572_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41433-021-01649-0","article-title":"Retinal non-perfusion in diabetic retinopathy","volume":"36","author":"Wykoff","year":"2022","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.exer.2023.109572_bib39","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acs.jproteome.0c01048","article-title":"Proteomic analysis of plasma sEVs reveals that TNFAIP8 is a new biomarker of cell proliferation in diabetic retinopathy","volume":"20","author":"Xiao","year":"2021","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/exnr.2000.7370","article-title":"Degeneration of cone photoreceptors induced by expression of the Mas1 protooncogene","volume":"163","author":"Xu","year":"2000","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.exer.2023.109572_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbrc.2020.05.029","article-title":"TNFAIP8 influences the motor function in mice after spinal cord injury (SCI) through meditating inflammation dependent on AKT","volume":"528","author":"Xue","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2023.109572_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2021.01.108","article-title":"Interleukin-1beta induces pericyte apoptosis via the NF-kappaB pathway in diabetic retinopathy","volume":"546","author":"Yun","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.exer.2023.109572_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7150\/ijbs.23268","article-title":"Tumor necrosis factor-alpha induced protein 8: pathophysiology, clinical significance, and regulatory mechanism","volume":"14","author":"Zhang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.exer.2023.109572_bib45","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2010.08.003","article-title":"Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy","volume":"1802","author":"Zhang","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523001938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523001938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:36:00Z","timestamp":1762148160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483523001938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"alternative-id":["S0014483523001938"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2023.109572","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNFAIP8 overexpression aggravates retinal pathophysiological features of diabetic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2023.109572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109572"}}